15,968 reports of this reaction
5.6% of all ALBUTEROL reports
#1 most reported adverse reaction
DYSPNOEA is the #1 most commonly reported adverse reaction for ALBUTEROL, manufactured by Amneal Pharmaceuticals NY LLC. There are 15,968 FDA adverse event reports linking ALBUTEROL to DYSPNOEA. This represents approximately 5.6% of all 283,047 adverse event reports for this drug.
Patients taking ALBUTEROL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is moderately reported among ALBUTEROL users, representing a notable but not dominant share of adverse events.
In addition to dyspnoea, the following adverse reactions have been reported for ALBUTEROL:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 15,968 FDA reports for ALBUTEROL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 5.6% of all adverse event reports for ALBUTEROL, making it one of the most commonly reported side effect.
If you experience dyspnoea while taking ALBUTEROL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.